Assenagon Asset Management’s Surgalign Holdings, Inc. Common Stock SRGA Stock Holding History

Assenagon Asset Management’s Portfolio SRGA Stock Details SRGA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-2,152	Closed	-$20K	–	1644
2022 Q1	$20K	Buy	+2,152	New	+$32.7K	﹤0.01%	1399
2021 Q4	–	Sell	-94,396	Closed	-$3.09M	–	1606
2021 Q3	$3.09M	Buy	94,396 +92,135	+4,075%	+$3.37M	0.01%	565
2021 Q2	$94K	Sell	2,261 -160	-7%	-$8.19K	﹤0.01%	1170
2021 Q1	$158K	Hold	2,421	–	–	﹤0.01%	1161
2020 Q4	$159K	Hold	2,421	–	–	﹤0.01%	959
2020 Q3	$131K	Sell	2,421 -228	-9%	-$17.4K	﹤0.01%	1087
2020 Q2	$253K	Buy	+2,649	New	+$197K	﹤0.01%	1038
2019 Q4	–	Sell	-2,380	Closed	-$204K	–	999
2019 Q3	$204K	Buy	2,380 +4	+0.2%	+$427	﹤0.01%	784
2019 Q2	$303K	Buy	+2,376	New	+$342K	﹤0.01%	915

Other funds holding SRGA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AWS

Atria Wealth Solutions New York $4.42B AUM 16.4% 1-Year Est. Return

CLG

Cooperman Leon G $3.05B AUM 42.78% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Assenagon Asset Management's SRGA Position: Q2 2022 in Review

Assenagon Asset Management sold out of Surgalign Holdings, Inc. Common Stock (SRGA) in Q2 2022, closing a stake of 2,152 shares — an estimated $20K sold.

Assenagon Asset Management first reported a position in SRGA in Q2 2019 and held it in 9 quarters. The position peaked at $3.09M in Q3 2021. 40 funds tracked by Wall St. Rank hold SRGA as of Q2 2022.

Assenagon Asset Management reported no remaining Surgalign Holdings, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
Assenagon Asset Management sold 2,152 Surgalign Holdings, Inc. Common Stock shares in Q2 2022, an estimated $20K.
Assenagon Asset Management first reported a position in Surgalign Holdings, Inc. Common Stock in Q2 2019 and held it in 9 quarters.
Assenagon Asset Management's Surgalign Holdings, Inc. Common Stock position peaked at $3.09M in Q3 2021.
40 funds tracked by Wall St. Rank held Surgalign Holdings, Inc. Common Stock as of Q2 2022.

Based on Assenagon Asset Management's 13F filing for Q2 2022, filed 27 Jul 2022.